RESUMEN
MAX is a conserved constitutive small phosphoprotein from a network of transcription factors that are extensively studied in tumorigenesis and whose functions affect cell proliferation, differentiation and death. Inspired by its higher expression during development and in regions involved in emotional behaviors, we hypothesized its involvement in cerebral changes caused by early-life stress. We studied the effects of repeated social stress during adolescence on behaviors and on MAX and its putative partner MYC. Thirty-day-old C57BL/6 male mice underwent brief daily social defeat stress from an adult aggressor for 21 days. Following social stress episodes and housing in social groups after each defeat, adolescent mice exhibit depressive-like, but not anxiety-like behaviors and show higher MAX nuclear immunoreactivity in hippocampal (HC) but not prefrontal cortical (PFC) neurons. Conversely, MAX immunoreactivity is lower in the striatum (ST) of defeated adolescents. The positive correlation between MAX and MYC levels in the PFC revealed disruptions in both the HC and ST. The changes in MAX protein levels are not due to differential gene expression or protein degradation in those regions, suggesting that posttranscriptional modifications occurred. These findings indicate that repeated, brief social defeat in adolescent male mice, combined with group housing, is a useful protocol to study a subtype of depression that is dissociated from generalized (non-social) anxiety. To our knowledge, this is the first report of an association between dysregulation of the MAX-MYC network in the brain and a behavior, suggesting a novel approach for exploiting the neuroplasticity associated with depression.
Asunto(s)
Factores de Transcripción Básicos con Cremalleras de Leucinas y Motivos Hélice-Asa-Hélice/genética , Encéfalo/fisiopatología , Trastorno Depresivo/genética , Trastorno Depresivo/fisiopatología , Modelos Animales de Enfermedad , Dominación-Subordinación , Medio Social , Factores de Edad , Animales , Ansiedad/genética , Ansiedad/fisiopatología , Mapeo Encefálico , Masculino , Ratones , Ratones Endogámicos BALB C , Red Nerviosa/fisiología , Plasticidad Neuronal/genética , Plasticidad Neuronal/fisiologíaRESUMEN
The traditional concept that effector T helper (Th) responses are mediated by Th1/Th2 cell subtypes has been broadened by the recent demonstration of two new effector T helper cells, the IL-17 producing cells (Th17) and the follicular helper T cells (Tfh). These new subsets have many features in common, such as the ability to produce IL-21 and to express the IL-23 receptor (IL23R), the inducible co-stimulatory molecule ICOS, and the transcription factor c-Maf, all of them essential for expansion and establishment of the final pool of both subsets. Tfh cells differ from Th17 by their ability to home to B cell areas in secondary lymphoid tissue through interactions mediated by the chemokine receptor CXCR5 and its ligand CXCL13. These CXCR5+ CD4+ T cells are considered an effector T cell type specialized in B cell help, with a transcriptional profile distinct from Th1 and Th2 cells. The role of Tfh cells and its primary product, IL-21, on B-cell activation and differentiation is essential for humoral immunity against infectious agents. However, when deregulated, Tfh cells could represent an important mechanism contributing to exacerbated humoral response and autoantibody production in autoimmune diseases. This review highlights the importance of Tfh cells by focusing on their biology and differentiation processes in the context of normal immune response to infectious microorganisms and their role in the pathogenesis of autoimmune diseases.
Asunto(s)
Enfermedades Autoinmunes/inmunología , Autoinmunidad/inmunología , Linfocitos T Colaboradores-Inductores/inmunología , Linfocitos B/inmunología , Linfocitos T CD4-Positivos/inmunología , Diferenciación Celular , Humanos , Interleucina-17/inmunología , Interleucinas/inmunología , Activación de Linfocitos/inmunología , Transducción de Señal , Células Th17/inmunología , Células Th2/inmunologíaRESUMEN
The traditional concept that effector T helper (Th) responses are mediated by Th1/Th2 cell subtypes has been broadened by the recent demonstration of two new effector T helper cells, the IL-17 producing cells (Th17) and the follicular helper T cells (Tfh). These new subsets have many features in common, such as the ability to produce IL-21 and to express the IL-23 receptor (IL23R), the inducible co-stimulatory molecule ICOS, and the transcription factor c-Maf, all of them essential for expansion and establishment of the final pool of both subsets. Tfh cells differ from Th17 by their ability to home to B cell areas in secondary lymphoid tissue through interactions mediated by the chemokine receptor CXCR5 and its ligand CXCL13. These CXCR5+ CD4+ T cells are considered an effector T cell type specialized in B cell help, with a transcriptional profile distinct from Th1 and Th2 cells. The role of Tfh cells and its primary product, IL-21, on B-cell activation and differentiation is essential for humoral immunity against infectious agents. However, when deregulated, Tfh cells could represent an important mechanism contributing to exacerbated humoral response and autoantibody production in autoimmune diseases. This review highlights the importance of Tfh cells by focusing on their biology and differentiation processes in the context of normal immune response to infectious microorganisms and their role in the pathogenesis of autoimmune diseases.
Asunto(s)
Humanos , Enfermedades Autoinmunes/inmunología , Autoinmunidad/inmunología , Linfocitos T Colaboradores-Inductores/inmunología , Linfocitos B/inmunología , Activación de Linfocitos/inmunología , Linfocitos T CD4-Positivos/inmunología , Transducción de Señal , Diferenciación Celular , Interleucinas/inmunología , Células Th2/inmunología , Interleucina-17/inmunología , Células Th17/inmunologíaRESUMEN
AIMS: To report nine additional well-defined cases with infiltrative myelopathy by paracoccidioidomycosis (PCM), to describe the specific lesions and infection-related stromal abnormalities, to review the literature on this type of involvement and to introduce a new cause of granulomatous lesions of bone marrow. METHODS AND RESULTS: Different bone marrow specimens were studied (aspirated smears, aspirated clots, biopsy imprints and biopsies) from nine patients with acute or subacute forms of PCM known to have PCM infiltrative myelopathy. CONCLUSIONS: The biopsy specimens were the best for demonstrating bone marrow involvement by PCM. The lesions varied from compact and focal granulomas with few fungal cells to numerous disseminated fungal cells within a loose granulomatous inflammatory reaction, with a continuum between these extremes suggesting a spectrum of immune response to the fungi. Other findings such as bone marrow fibrosis, parenchymal coagulative necrosis and bone necrosis were also observed in the affected areas.
Asunto(s)
Enfermedades de la Médula Ósea/patología , Médula Ósea/patología , Paracoccidioidomicosis/complicaciones , Adolescente , Adulto , Biopsia , Enfermedades de la Médula Ósea/etiología , Examen de la Médula Ósea , Niño , Femenino , Humanos , Masculino , Persona de Mediana EdadRESUMEN
Sudden-onset bilateral deafness as a clinical manifestation of hyperleukocytosis in chronic myeloid leukemia (CML) is a rare occurrence. We found only 27 clinical descriptions in 16 published papers. In this work, the authors present a review on deafness in CML and describe a new case with prominent hyperleukocytosis, where the neurological findings suggest slowing of the circulation through small blood vessels in the brainstem as the cause of deafness. The evolution was good after treatment. To our knowledge, this is the second case documented with electrical auditory brainstem-evoked potentials and the first with magnetic resonance imaging.
Asunto(s)
Sordera/etiología , Leucemia Mielógena Crónica BCR-ABL Positiva/complicaciones , Leucocitosis/complicaciones , Arteria Basilar/fisiopatología , Velocidad del Flujo Sanguíneo , Viscosidad Sanguínea , Tronco Encefálico/irrigación sanguínea , Sordera/sangre , Oído Interno/irrigación sanguínea , Femenino , Hemorragia/complicaciones , Hemorragia/etiología , Humanos , Imagen por Resonancia Magnética , Masculino , Microcirculación/fisiopatología , Persona de Mediana EdadRESUMEN
A síndrome de Garcin é rara. O objetivo deste trabalho é descrever um caso relacionado a linfoma näo-Hodgkin. Um paciente de 41 anos desenvolveu comprometimento sucessivo de múltiplos nervos cranianos. Do lado direito havia alteraçöes de todos os nervos cranianos, caracterizando a síndrome de Garcin. Exérese de linfonodo revelou linfoma näo-Hodgkin de grandes células, e observou-se infiltraçäo difusa da medula óssea. O líquido cefalorraquiano mostrou pleocitose com 100 por cento de imunoblastos. A tomografia computadorizada de crânio näo revelou massas. Esta é a primeira descriçäo clínica da síndrome de Garcin completa causada por infiltraçäo linfomatosa difusa dos nervos cranianos